Brighton Jones LLC raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 98.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,770 shares of the medical instruments supplier’s stock after buying an additional 877 shares during the period. Brighton Jones LLC’s holdings in Becton, Dickinson and Company were worth $401,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of BDX. Livelsberger Financial Advisory purchased a new stake in shares of Becton, Dickinson and Company during the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC purchased a new stake in Becton, Dickinson and Company during the 3rd quarter valued at $33,000. Tompkins Financial Corp boosted its holdings in shares of Becton, Dickinson and Company by 44.2% during the third quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 46 shares during the period. Sound Income Strategies LLC raised its position in Becton, Dickinson and Company by 35.8% during the 3rd quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier’s stock valued at $40,000 after purchasing an additional 44 shares during the last quarter. Finally, Kennebec Savings Bank purchased a new stake in Becton, Dickinson and Company in the 3rd quarter worth approximately $46,000. 86.97% of the stock is owned by institutional investors.

Insider Activity

In other Becton, Dickinson and Company news, EVP Roland Goette sold 638 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $219.03, for a total transaction of $139,741.14. Following the completion of the transaction, the executive vice president now owns 14,217 shares in the company, valued at $3,113,949.51. This trade represents a 4.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael David Garrison sold 2,838 shares of Becton, Dickinson and Company stock in a transaction that occurred on Thursday, December 19th. The stock was sold at an average price of $223.33, for a total value of $633,810.54. Following the completion of the sale, the executive vice president now directly owns 6,141 shares in the company, valued at approximately $1,371,469.53. The trade was a 31.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,844 shares of company stock worth $2,210,716 over the last 90 days. Corporate insiders own 0.36% of the company’s stock.

Wall Street Analysts Forecast Growth

BDX has been the subject of a number of research analyst reports. StockNews.com lowered Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a research note on Wednesday, December 18th. Citigroup raised shares of Becton, Dickinson and Company from a “neutral” rating to a “buy” rating and raised their target price for the stock from $255.00 to $275.00 in a research report on Tuesday, October 1st. Finally, Evercore ISI boosted their price target on shares of Becton, Dickinson and Company from $286.00 to $290.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $283.50.

View Our Latest Stock Analysis on Becton, Dickinson and Company

Becton, Dickinson and Company Price Performance

Shares of BDX opened at $243.69 on Monday. The firm has a market cap of $70.67 billion, a PE ratio of 41.02, a P/E/G ratio of 1.72 and a beta of 0.39. Becton, Dickinson and Company has a 1-year low of $218.75 and a 1-year high of $248.42. The company has a current ratio of 1.17, a quick ratio of 0.74 and a debt-to-equity ratio of 0.69. The firm has a fifty day simple moving average of $228.08 and a two-hundred day simple moving average of $233.08.

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $3.81 EPS for the quarter, topping analysts’ consensus estimates of $3.77 by $0.04. The business had revenue of $5.44 billion during the quarter, compared to analysts’ expectations of $5.38 billion. Becton, Dickinson and Company had a return on equity of 14.89% and a net margin of 8.55%. The business’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.42 earnings per share. On average, equities analysts anticipate that Becton, Dickinson and Company will post 14.42 EPS for the current year.

Becton, Dickinson and Company Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 9th were issued a dividend of $1.04 per share. This represents a $4.16 annualized dividend and a dividend yield of 1.71%. The ex-dividend date of this dividend was Monday, December 9th. This is an increase from Becton, Dickinson and Company’s previous quarterly dividend of $0.95. Becton, Dickinson and Company’s dividend payout ratio is 70.03%.

About Becton, Dickinson and Company

(Free Report)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Featured Articles

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX – Free Report).

Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Company and related companies with MarketBeat.com’s FREE daily email newsletter.